This role focuses on early development (phase I) and late stage (phase II-III) safety science activities within a global biotechnology company fighting cancer
Job Summary
This role focuses on early development (phase I) and late stage (phase II-III) safety science activities within a global biotechnology company fighting cancer.
The position requires leading signal evaluation, safety monitoring, and the preparation of critical regulatory documents such as Investigator Brochures and Package Inserts.
BeOne offers a comprehensive benefits package including medical, dental, vision, 401(k), and opportunities for equity ownership.
Matching Summary
This role focuses on early development (phase I) and late stage (phase II-III) safety science activities within a global biotechnology company fighting cancer.
Salary
Base: $154,300.00 - $204,300.00 annually; Bonus/Equity: Annual bonus plan eligible; Benefits: Medical, Dental, Vision, 401(k), FSA/HSA, Life Insurance, PTO
Skills & Requirements
Must-have
Pharmacovigilance analytical role experience
Signal detection and assessment expertise
Safety data analysis and reporting
Regulatory submission authoring
MedDRA knowledge
Nice-to-have
Collaborative cross-functional teamwork
Patient-first mindset
Experience with immuno-oncology
Data mining tool proficiency
Global stakeholder communication
Key Requirements
PharmD or PhD in medical/biological science
4+ years pharmacovigilance analytical experience
RN with 8+ years pharmacovigilance experience
MD with residency plus 2+ years industry experience